Management of Fishy Odor from Erosions with Secondary Bacterial Infection
A fishy odor in the context of skin erosions strongly suggests methicillin-resistant Staphylococcus aureus (MRSA) infection and requires immediate empiric coverage with vancomycin or another agent effective against both MRSA and streptococci 1, 2.
Immediate Assessment and Treatment Algorithm
Step 1: Recognize the Clinical Significance
The fishy odor is a distinctive clinical sign that should immediately alert you to screen for MRSA infection. This peculiar odor, combined with generalized erythema and erosions, has been specifically documented as a hallmark of MRSA superinfection 1. In the reported cases, this odor consistently disappeared with vancomycin therapy, confirming the clinical correlation.
Step 2: Initiate Empiric Antibiotic Therapy
Start vancomycin immediately as empiric therapy for severe nonpurulent skin and soft tissue infection with suspected MRSA 2. The IDSA guidelines specifically recommend vancomycin or another antimicrobial effective against both MRSA and streptococci when there is:
- Evidence of MRSA infection elsewhere
- Purulent drainage (or in this case, erosions with fishy odor)
- Systemic signs of infection (SIRS)
For severely compromised patients, consider broad-spectrum coverage with vancomycin plus piperacillin-tazobactam or a carbapenem 2.
Step 3: Obtain Cultures
While initiating empiric therapy, obtain wound cultures from the erosions. However, recognize that MRSA in this context has shown consistent vancomycin sensitivity 1, so don't delay treatment waiting for culture results.
Step 4: Duration and Monitoring
- Treat for a minimum of 5 days, extending therapy if the infection has not improved 2
- Monitor for disappearance of the fishy odor and resolution of erythema as clinical markers of treatment response 1
- The odor should resolve with appropriate vancomycin therapy
Important Clinical Pitfalls
Do not mistake this for simple wound colonization. The fishy odor is a specific indicator of active MRSA infection requiring systemic antibiotics, not just topical management 1.
Avoid inadequate initial coverage. Starting with antibiotics that don't cover MRSA (such as cephalexin alone) will lead to treatment failure and potentially increased morbidity 2.
Adjunctive Measures
Beyond antibiotics, address:
- Elevation of the affected area 2
- Treatment of underlying predisposing factors such as edema or dermatologic conditions 2
- Consider decolonization strategies after acute infection resolves (intranasal mupirocin twice daily for 5 days plus daily chlorhexidine or dilute bleach baths) to prevent recurrence 2
Hospitalization Criteria
Admit the patient if there is:
- SIRS or hemodynamic instability
- Altered mental status
- Concern for deeper or necrotizing infection
- Severe immunocompromise
- Poor adherence anticipated 2